{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:11:06Z","timestamp":1777522266145,"version":"3.51.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1016\/s0006-3223(03)00321-4","type":"journal-article","created":{"date-parts":[[2003,7,16]],"date-time":"2003-07-16T13:31:26Z","timestamp":1058362286000},"page":"453-464","source":"Crossref","is-referenced-by-count":168,"title":["Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome"],"prefix":"10.1016","volume":"54","author":[{"given":"Scott W","family":"Woods","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Breier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B","family":"Zipursky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana O","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Addington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tandy J","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy R","family":"Lindborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Tohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H","family":"McGlashan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0006-3223(03)00321-4_BIB1","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1192\/bjp.177.3.207","article-title":"West London first episode study of schizophrenia","volume":"177","author":"Barnes","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/bjp.174.1.23","article-title":"Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol","volume":"174","author":"Beasley","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0920-9964(00)00144-4","article-title":"Duration of untreated psychosis predicts treatment outcome in an early psychosis program","volume":"47","author":"Black","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB5","series-title":"Dementia Praecox or the Group of the Schizophrenias","author":"Bleuler","year":"1911"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/PL00007545","article-title":"Deficit states in schizophrenia and their association with the length of illness and gender","volume":"251","author":"Bottlender","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB7","first-page":"3","article-title":"Abnormal involuntary movement scale (AIMS)","volume":"4","author":"Branch","year":"1975","journal-title":"Early Clin Drug Eval Unit Intercom"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0447.1999.tb10830.x","article-title":"Duration of untreated psychosis and 12-month outcome in first-episode psychosis","volume":"100","author":"Carbone","year":"1999","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1037\/0021-843X.103.2.171","article-title":"Putatively psychosis-prone subjects 10 years later","volume":"103","author":"Chapman","year":"1994","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB10","first-page":"15","article-title":"Duration of untreated psychosis and symptomatic outcome among first episode schizophrenic patients in Hong Kong","volume":"36","author":"Chen","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB11","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1176\/ajp.157.1.60","article-title":"Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?","volume":"157","author":"Craig","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","article-title":"A randomised controlled trial of prophylactic neuroleptic treatment","volume":"148","author":"Crow","year":"1986","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB14","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1176\/ajp.156.9.1328","article-title":"Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents","volume":"156","author":"Davidson","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-9964(01)00243-2","article-title":"Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia","volume":"51","author":"DeGrazia","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0924-9338(00)00234-0","article-title":"Duration of untreated psychosis and the long-term course of schizophrenia","volume":"15","author":"de Haan","year":"2000","journal-title":"Eur Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1192\/bjp.177.6.511","article-title":"Causes and consequences of duration of untreated psychosis in schizophrenia","volume":"177","author":"Drake","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1192\/S0007125000297754","article-title":"Prolonged recovery in first-episode psychosis","volume":"172","author":"Edwards","year":"1998","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/00332747.1992.11024572","article-title":"Early intervention for first episodes of schizophrenia","volume":"55","author":"Falloon","year":"1992","journal-title":"Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB20","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1176\/appi.ajp.157.11.1829","article-title":"Features of structural brain abnormality detected in first-episode psychosis","volume":"157","author":"Fannon","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1993.01820210073009","article-title":"Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset","volume":"50","author":"Gibbons","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB22","first-page":"18","article-title":"The impact of duration of untreated psychotic symptoms on treatment response of delusions and hallucinations","volume":"36","author":"Gunduz","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB23","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3956(98)00008-9","article-title":"Delay to first antipsychotic medication in schizophrenia\u2014impact on symptomatology and clinical course of illness","volume":"32","author":"Haas","year":"1998","journal-title":"J Psychiatr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB25","doi-asserted-by":"crossref","unstructured":"Hafner H, Maurer K, Loffler W, Fatkenheuer B, an der Heiden W, Riecher-Rossler A, et al (1994): The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry Suppl April:29\u201338","DOI":"10.1192\/S0007125000292714"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","article-title":"Global assessment of functioning. A modified scale","volume":"36","author":"Hall","year":"1995","journal-title":"Psychosomatics"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB27","unstructured":"Hawkins KA, Edwards KB, Bobulinski M, Hoffman RE, McGlashan TH (2001): Psychosis prodrome, conversion, and neuropsychological course. Paper presented at annual meeting of the American Psychiatric Association; May 9, 2001; New Orleans, LA"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB28","doi-asserted-by":"crossref","unstructured":"Hawkins KA, Quinlan D, Miller TJ, McGlashan TH, Zipursky RB, Perkins DO, et al (in press): Factorial structure of the scale of prodromal symptoms. Schizophr Res","DOI":"10.1016\/S0920-9964(03)00053-7"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/oxfordjournals.schbul.a006897","article-title":"Informed consent in early psychosis research","volume":"27","author":"Heinssen","year":"2001","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0447.1990.tb06486.x","article-title":"Twenty years\u2019 follow-up of first psychiatric presentation for schizophrenia","volume":"81","author":"Helgason","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1176\/appi.ajp.157.5.808","article-title":"Untreated initial psychosis","volume":"157","author":"Ho","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB32","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1176\/appi.ajp.157.11.1824","article-title":"Lack of association between duration of untreated illness and severity of cognitive and structural brain deficits at the first episode of schizophrenia","volume":"157","author":"Hoff","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB33","first-page":"42","article-title":"Duration of initially untreated psychosis (DUP) and outcome 10 years after onset","volume":"36","author":"Hopkins","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1532-5415.1999.tb01595.x","article-title":"Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients","volume":"47","author":"Jeste","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.148.2.115","article-title":"The Northwick Park Study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission","volume":"148","author":"Johnstone","year":"1986","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/archpsyc.58.2.158","article-title":"Diagnosing schizophrenia in the initial prodromal phase","volume":"58","author":"Klosterkotter","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1592\/phco.22.11.841.33629","article-title":"Olanzapine-associated diabetes mellitus","volume":"22","author":"Koller","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB39","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archpsyc.59.11.1021","article-title":"An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients","volume":"59","author":"Koro","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(99)00169-3","article-title":"Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis","volume":"45","author":"Larsen","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1192\/S0007125000297717","article-title":"Early intervention, untreated psychosis and the course of early schizophrenia","volume":"172","author":"Linszen","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.131.1.63","article-title":"Ten-year follow-up study of Chinese schizophrenics in Hong Kong","volume":"131","author":"Lo","year":"1977","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB43","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1176\/ajp.149.9.1183","article-title":"Duration of psychosis and outcome in first-episode schizophrenia","volume":"149","author":"Loebel","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-0447.1999.tb10880.x","article-title":"Progressive atrophy of the frontal lobes in first-episode schizophrenia","volume":"100","author":"Madsen","year":"1999","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/BIP-100104194","article-title":"Accounting for dropout bias using mixed-effects models","volume":"11","author":"Mallinckrodt","year":"2001","journal-title":"J Biopharm Stat"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB46","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/009286150103500418","article-title":"Type I error rates from mixed effects model repeated measures compared with fixed effects ANOVA with missing values imputed via LOCF","volume":"35","author":"Mallinckrodt","year":"2001","journal-title":"Drug Information J"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB47","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archpsyc.1981.01780320056006","article-title":"Schizophrenia. A follow-up study of the results of five forms of treatment","volume":"38","author":"May","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1192\/S0007125000297584","article-title":"Early detection and intervention of schizophrenia","volume":"172","author":"McGlashan","year":"1998","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-9964(01)00238-9","article-title":"Psychosis treatment prior to psychosis onset","volume":"51","author":"McGlashan","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/schbul\/22.2.201","article-title":"Early detection and intervention with schizophrenia","volume":"22","author":"McGlashan","year":"1996","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB51","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/oxfordjournals.schbul.a006896","article-title":"Pre-onset detection and intervention research in schizophrenic psychoses","volume":"27","author":"McGlashan","year":"2001","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-9964(02)00439-5","article-title":"The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design","volume":"61","author":"McGlashan","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/S0007125000297572","article-title":"Verging on reality","volume":"172","author":"McGorry","year":"1998","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/schbul\/22.2.305","article-title":"EPPIC","volume":"22","author":"McGorry","year":"1996","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","article-title":"Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms","volume":"59","author":"McGorry","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB57","first-page":"35","article-title":"Diagnosis and symptom assessment in the schizophrenia prodrome","volume":"53","author":"Miller","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB58","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1176\/appi.ajp.159.5.863","article-title":"Prospective diagnosis of the prodrome for schizophrenia","volume":"159","author":"Miller","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1022034115078","article-title":"Symptom assessment in schizophrenic prodromal states","volume":"70","author":"Miller","year":"1999","journal-title":"Psychiatr Q"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0920-9964(02)00440-1","article-title":"The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the \u201cprodromal\u201d sample","volume":"61","author":"Miller","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/oxfordjournals.schbul.a033442","article-title":"The initial prodrome in schizophrenia","volume":"26","author":"Moller","year":"2000","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB62","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1600-0447.1994.tb05872.x","article-title":"Health and economic evaluation in schizophrenia","volume":"382","author":"Moscarelli","year":"1994","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/schbul\/22.2.223","article-title":"Risk factors of psychosis","volume":"22","author":"Olin","year":"1996","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB65","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ps.53.3.342","article-title":"Treatment histories of patients with a syndrome putatively prodromal for schizophrenia","volume":"53","author":"Preda","year":"2002","journal-title":"Psychiatr Serv"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB66","first-page":"29","article-title":"Duration of initially untreated psychosis as a primary predictor of poor long term outcome over the lifetime trajectory of schizophrenia","volume":"36","author":"Quinn","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB67","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1176\/ajp.143.9.1155","article-title":"Outcome study of first-episode psychosis. I","volume":"143","author":"Rabiner","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB68","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder","volume":"156","author":"Robinson","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0006-3223(00)00872-6","article-title":"H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients","volume":"48","author":"Sacchetti","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0920-9964(01)00234-1","article-title":"Preventing severe mental illnesses\u2014new prospects and ethical challenges","volume":"51","author":"Schaffner","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB71","first-page":"9","article-title":"Duration of untreated psychosis is associated with a poor treatment response in schizophrenia","volume":"36","author":"Schroder","year":"1999","journal-title":"Schizopr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB72","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1017\/S0033291797005722","article-title":"Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia","volume":"27","author":"Scully","year":"1997","journal-title":"Psychol Med"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB74","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1001\/jama.281.20.1877","article-title":"Schizophrenia researchers striving for early detection and intervention","volume":"281","author":"Stephenson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1176\/ajp.84.1.105","article-title":"The onset of schizophrenia","volume":"7","author":"Sullivan","year":"1927","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB76","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1176\/ajp.153.4.519","article-title":"Course of treatment response in first-episode and chronic schizophrenia","volume":"153","author":"Szymanski","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB77","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/070674377101600604","article-title":"Early schizophrenia","volume":"16","author":"Varsamis","year":"1971","journal-title":"Can Psychiatr Assoc J"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB78","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0920-9964(00)00072-4","article-title":"Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-admitted patients","volume":"49","author":"Verdoux","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB79","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1017\/S0033291700035108","article-title":"Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia","volume":"25","author":"Waddington","year":"1995","journal-title":"Psychol Med"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB80","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/00004583-200212000-00015","article-title":"Effects of development on olanzapine-associated adverse events","volume":"41","author":"Woods","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB81","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S1092852900008609","article-title":"The prodromal patient","volume":"6","author":"Woods","year":"2001","journal-title":"CNS Spectrums"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB82","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0006-3223(00)00973-2","article-title":"Consistency of atypical antipsychotic superiority to placebo in recent clinical trials","volume":"49","author":"Woods","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB83","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/schbul\/17.2.325","article-title":"Neuroleptics and the natural course of schizophrenia","volume":"17","author":"Wyatt","year":"1991","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1017\/S0033291796004345","article-title":"Long-term morbidity associated with delayed treatment of first admission schizophrenic patients","volume":"27","author":"Wyatt","year":"1997","journal-title":"Psychol Med"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB86","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/00048679609062654","article-title":"The initial prodrome in psychosis","volume":"30","author":"Yung","year":"1996","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB87","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1192\/S0007125000297602","article-title":"Prediction of psychosis. A step towards indicated prevention of schizophrenia","volume":"172","author":"Yung","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(03)00321-4_BIB88","doi-asserted-by":"crossref","unstructured":"Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al (2003): Psychosis prediction: 12-month follow up of a high-risk (\u201cprodromal\u201d) group. Schizophr Res 60:21\u201332","DOI":"10.1016\/S0920-9964(02)00167-6"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322303003214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322303003214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:21:33Z","timestamp":1682529693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322303003214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0006322303003214"],"URL":"https:\/\/doi.org\/10.1016\/s0006-3223(03)00321-4","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}